Use of the Leksell gamma knife in the treatment of prolactinoma patients

Clinical Endocrinology

Volumn 70, Issue 5, 2009, Pages 732-741

  Ježková, Jana ^a   Hána, Václav ^a   Kršek, Michal ^a   Weiss, Vladimír ^a   Vladyka, Vilibald ^b   Liščák, Roman ^b   Vymazal, Josef ^b   Pecen, Ladislav ^c   Marek, Josef ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

^c INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; LISURIDE; TERGURIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HORMONE ACTION; HUMAN; HYPOPHYSIS FUNCTION; MALE; PRIORITY JOURNAL; PROLACTINOMA; RADIATION DOSE; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; DOPAMINE AGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PREGNANCY; PROLACTIN; PROLACTINOMA; RADIOSURGERY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63149148886     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03384.x     Document Type: Article

References (66)

1. Molitch, M.E. (1995) Prolactinoma. In : S. Melmed ed. The Pituitary. Blackwell Science, Cambridge, MA, 443 477.
2. Ciccarelli, A., Daly, A.F. Beckers, A. (2005) The epidemiology of prolactinomas. Pituitary, 8, 3 6.
3. Molitch, M.E., Elton, R.L., Blackwell, R.E. et al. (1985) Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. Journal of Clinical Endocrinology and Metabolism, 60, 698 705.
4. Bevan, J.S., Webster, J., Burke, C.W. et al. (1992) Dopamine agonist and pituitary tumor shrinkage. Endocrine Reviews, 13, 220 240.
5. Vance, M.L., Evans, W.S. Thorner, M.O. (1984) Drugs five years later. Bromocriptine. Annals of Internal Medicine, 100, 78 91.
6. Liuzzi, A., Dallabonzana, D., Oppizzi, G. et al. (1985) Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. New England Journal of Medicine, 313, 656 659.
7. Berezin, M., Shimon, I. Hadani, M. (1995) Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma). Journal of Endocrinological Investigation, 18, 436 441.
8. Muratori, M., Arosio, M., Gambino, G. et al. (1997) Use of cabergoline in the long-treatment of hyperprolactinemic and acromegalic patients. Journal of Endocrinological Investigation, 20, 537 546.
9. Verhelst, J., Abs, R., Maiter, D. et al. (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. Journal of Clinical Endocrinology and Metabolism, 84, 2518 2522.
10. Di Sarno, A., Landi, M.L., Cappabianca, P. et al. (2001) Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. Journal of Clinical Endocrinology and Metabolism, 86, 5256 5261.
11. Colao, A., Di Sarno, A., Sarnacchiaro, F. et al. (1997) Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. Journal of Clinical Endocrinology and Metabolism, 82, 876 883.
12. Molitch, M.E. (2003) Dopamine resistance of prolactinomas. Pituitary, 6, 19 27.
13. Webster, J. (1996) A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinemia and inhibition lactation. Drug Safety, 14, 228 238.
14. Rains, C.P., Bryson, H.M. Fitton, A. (1995) Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinemia and inhibition lactation. Drug, 49, 255 279.
15. Hardy, J. (1984) Transsphenoidal microsurgery of prolactinomas. In : P.M. Black, N.T. Zervas, E.C. Ridgway, J.B. Martin eds. Secretory Tumors of the Pituitary Gland. Raven Press, New York, 73 81.
16. Fahlbusch, R. Buchfelder, M. (1985) Present status of neurosurgery in the treatment of prolactinomas. Neurosurgical Review, 8, 195 205.
17. Charpentier, G., de Plunkett, T., Jedynak, P. et al. (1985) Surgical treatment of prolactinoma. Short- and long-term results, prognostic factors. Hormone Research, 22, 222 227.
18. Webster, J., Page, M.D., Bevan, J.S. et al. (1992) Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function test. Clinical Endocrinology, 36, 35 44.
19. Feigenbaum, S.L., Downey, D.E., Wilson, C.B. et al. (1996) Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up. Journal of Clinical Endocrinology and Metabolism, 81, 1711 1719.
20. Minniti, G., Traish, D., Ashley, A. et al. (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. Journal of Clinical Endocrinology and Metabolism, 90, 800 804.
21. Becker, G., Kocher, M., Kortmann, R.D. et al. (2002) Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlentherapie und Onkologie, 4, 173 186.
22. Levy, R.P., Fabrikant, J.I. Frankel, K.A. (1991) Heavy charged particle radiosurgery of the pituitary gland: clinical result of 840 patients. Stereotactic and Functional Neurosurgery, 57, 22 35.
23. Morange-Ramos, I., Regis, J., Dufour, H. et al. (1998) Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochirurgica, 140, 437 443.
24. Kim, M.S., Lee, S.I. Sim, J.H. (1999) Gamma knife radiosurgery for functioning pituitary microadenomas. Stereotactic and Functional Neurosurgery, 72 (Suppl. 1 119 124.
25. Landolt, A.M. Lomax, N. (2000) Gamma knife radiosurgery for prolactinomas. Journal of Neurosurgery, 93 (Suppl. 3 14 18.
26. Petrovich, Z., Yu, C., Gianotta, S.L. et al. (2003) Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery, 53, 51 59, discussion, 59 61.
27. Pouratian, N., Sheehan, J., Jagannathan, J. et al. (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery, 59, 255 264.
28. Ježková, J., Marek, J., Hána, V. et al. (2006) Gamma knife radiosurgery for acromegaly - long-term experience. Clinical Endocrinology, 64, 588 598.
29. Novotný, J. Jr., Novotný, J., Vymazal, J. et al. (1998) Assessment of the accuracy of stereotactic target localization using magnetic resonance imaging: phantom study. Journal of Neurosurgery, 1, 99 111.
30. Dallabonzana, D., Liuzzi, A., Oppizzi, G. et al. (1986) Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivate teguride. Journal of Clinical Endocrinology and Metabolism, 63, 1002 1007.
31. Johnston, D.G., Prescott, R.V., Kendall-Taylor, P. et al. (1983) Hyperprolactinemia. Long-term effects of bromocriptine. American Journal of Medicine, 75, 868 874.
32. Moriondo, P., Travaglini, P., Nissim, M. et al. (1985) Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal. Journal of Clinical Endocrinology and Metabolism, 60, 764 772.
33. Webster, J., Piscitelli, G., Polli, A. et al. (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline comparative study group. New England Journal of Medicine, 331, 904 909.
34. Cannavo, S., Curto, L., Squadrito, S. et al. (1999) Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma. Journal of Endocrinological Investigation, 22, 354 359.
35. Ferrari, C., Paracchi, A., Mattei, A.M. et al. (1992) Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta Endocrinologica, 126, 489 494.
36. Colao, A., Di Sarno, A., Landi, M.L. et al. (2000) Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. Journal of Clinical Endocrinology and Metabolism, 85, 2247 2252.
37. Johnston, D.G., Hall, K., Kendall-Taylor, P. et al. (1984) Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography. Lancet, 2, 187 192.
38. Wang, C., Lam, K.S., Ma, J.T. et al. (1987) Long-term treatment of hyperprolactinemia with bromocriptine: effect of drug withdrawal. Clinical Endocrinology, 27, 363 371.
39. Rasmussen, C., Bergh, T. Wide, L. (1987) Prolactin secretion and menstrual function after long-term bromocriptine treatment. Fertility and Sterility, 48, 550 554.
40. Biswas, M., Smith, J., Jadon, D. et al. (2005) Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clinical Endocrinology, 63, 26 31.
41. Colao, A., Di Sarno, A., Cappabianca, P. et al. (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. New England Journal of Medicine, 349, 2023 2033.
42. Pollock, B.E., Nippoldt, T.B., Stafford, S.L. et al. (2002) Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. Journal of Neurosurgery, 97, 525 530.
43. Pan, L., Zhang, N., Wang, E.M. et al. (2000) Gamma knife radiosurgery as a primary treatment for prolactinomas. Journal of Neurosurgery, 93 (Suppl. 3 10 13.
44. Kim, S.H., Huh, R., Chang, J.W. et al. (1999) Gamma knife radiosurgery for functioning pituitary adenomas. Stereotactic and Functional Neurosurgery, 72 (Suppl. 1 101 110.
45. Sheehan, J.P., Niranjan, A., Sheehan, M.J. et al. (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. Journal of Neurosurgery, 102, 678 691.
46. Snyder, P.J., Fowble, B.F., Schatz, N.J. et al. (1986) Hypopituitarism following radiation therapy of pituitary adenomas. American Journal of Medicine, 81, 457 462.
47. Littley, M.D., Shalet, S.M., Beardwell, C.G. et al. (1989) Hypopituitarism following external radiotherapy for pituitary tumours in adults. Quarterly Journal of Medicine, 70, 145 160.
48. Tsang, R.W., Brierley, J.D., Panzarella, T. et al. (1994) Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. International Journal of Radiation Oncology, Biology, Physics, 30, 557 565.
49. Hayashi, M., Izawa, M., Hiyama, H. et al. (1999) Gamma knife radiosurgery for pituitary adenomas. Stereotactic and Functional Neurosurgery, 72 (Suppl. 1 111 118.
50. Izawa, M., Hayashi, M., Nakaya, K. et al. (2000) Gamma knife radiosurgery for pituitary adenomas. Journal of Neurosurgery, 93 (Suppl. 3 19 22.
51. Lim, Y.L., Leem, W., Kim, T.S. et al. (1998) Four years′ experience in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotactic and Functional Neurosurgery, 70 (Suppl. 1 95 109.
52. Martinez, R., Bravo, G., Burzaco, J. et al. (1998) Pituitary tumors and gamma knife radiosurgery. Clinical experience with more than two years of follow-up. Stereotactic and Functional Neurosurgery, 70 (Suppl. 1 110 118.
53. Mokry, M., Ramschak-Schwarzer, S., Simbrunner, J. et al. (1999) A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotactic and Functional Neurosurgery, 72 (Suppl. 1 88 100.
54. Vladyka, V., Liščák, R., Novotný, J. Jr. et al. (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery, 52, 309 317.
55. Ganz, J.C., Backlund, E.O. Thorsen, F.A. (1993) The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotactic and Functional Neurosurgery, 61 (Suppl. 1 30 37.
56. Mitsumori, M., Shrieve, D.C., Alexander, IIIE. et al. (1998) Initial clinical results of linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. International Journal of Radiation Oncology, Biology, Physics, 42, 573 580.
57. Choi, J.Y., Chang, J.H., Chang, J.W. et al. (2003) Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery. Yonsei Medical Journal, 44, 602 607.
58. Kuo, J.S., Chen, J.C.T., Cheng, Y. et al. (2004) Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes. Neurosurgery, 54, 1385 1392.
59. Voges, J., Kocher, M., Runge, M. et al. (2006) Linear accelerator radiosurgery for pituitary macroadenomas. Cancer, 107, 1355 1364.
60. Antunes, J.L., Housepian, E.M. Frantz, A.G. (1977) Prolacting-secreting pituitary tumors. Annals of Neurology, 2, 148 153.
61. Gómez, F., Reyes, F.I. Faimen, C. (1977) Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. American Journal of Medicine, 62, 648 660.
62. Grossman, A., Cohen, B.L., Charlesworth, M. et al. (1984) Treatment of prolactinomas with megavoltage radiotherapy. British Medical Journal (Clinical Research Edition), 228, 1105 1109.
63. Johnston, D.G., Hall, K., Kendall-Taylor, P. et al. (1986) The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography. Clinical Endocrinology, 24, 675 685.
64. Mehta, A.E., Reyes, F.I. Faiman, C. (1987) Primary radiotherapy of prolactinomas. 8- to 15-year follow-up. American Journal of Medicine, 83, 49 58.
65. Tsagarakis, S., Grossman, A., Plowman, P.N. et al. (1991) Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up. Clinical Endocrinology, 34, 399 406.
66. Zierhut, D., Flentje, M., Adolph, J. et al. (1995) External radiotherapy of pituitary adenomas. International Journal of Radiation Oncology, Biology, Physics, 33, 307 314.